Abstract：Objective To compare the treatment outcome and prognostic factors in patients with advanced cervical cervical cancer between Han and Uygur in Xinjiang district. Methods 204 patients with advanced cervical cancer were retrospectively analyzed. Eighty patients were Han 80 and 124 were Uyghur. 100 patients received radiotherapy alone and 49 with concurrent radiochemotherapy, and 55 had brachytherapy followed by surgery. The survival rate was calculated by Kaplan-Meier method and the difference was compared by Logrank test. Multivariate analysis was performed using Cox regression model. Results The follow-up rate was 97.5%. The number of patients with at least 5 years of follow up was 102. The 1-,3-and 5-year overall survival rates in Han and Uygur patients were 81.2%, 66.3%, 51.4% and 83.4%, 62.8%, 49.2%,respectively (χ2=3.21,P=0.273). Univariate analysis showed that parity, geographical distribution, pathological type, clinical stage, lymph node involvement and treatment were prognostic factors for overall survival (χ2=2.35, 11.34, 7.12, 6.73, 4.79, 13.60, P=0.049, 0.029, 0.031, 0.037, 0.041, 0.021). Multivariate analysis showed that parity, geographical distribution, pathological type, clinical stage, lymph node involvement and treatment were independent prognostic factors for overall survival (χ2=8.36, 24.94, 10.69, 5.63, 9.50, P=0.002, 0.001, 0.021, 0.018, 0.031). Conclusions There is no significant difference in overall survival rate of patients with advanced cervical cancer between Han and Uighur. Patients with parity more than or equal to 3 times, advanced clinical stage or adenocarcinoma have poor prognoses.
HUERXIDAN·Niyazi,ZHANG Lei,BAO Yong-xing. Comparison of prognostic factors and outcome of patients with advanced cervical cancer between Han and Uygur in Xinjiang district[J]. Chinese Journal of Radiation Oncology, 2012, 21(6): 540-542.
[1] 李庭芳,古丽娜·库尔班,王涛,等.新疆伽师县夏普桃勒乡妇女宫颈癌防治研究.新疆医学院学报,2010,19:199-203. [2] 李洁,刘宝印,zur Hausen H,等.中国妇女宫颈癌组织中人乳头瘤病毒感染及其地理分布调查.中华实验和临床病毒学杂志,1996,10:50-55. [3] Muoz N, Franceschi S, Bosetti C,et al. Role of parity and human papillomavirus in cervical cancer:the IARC multicentric case control study. Lancet,2002,359:1093-1101. [4] 柳菊,韩存芝,何传泰.中国宫颈癌的病因学研究及防治.中国肿瘤,2011,10:280. [5] 李庭芳,陈锐.宫颈癌临床流行病学概述.实用医院临床杂志,2005,2:19-22. [6] 李秀娟.宫颈癌流行病学及高危因素研究进展. 实用医技杂志,2006,13:3517-3518. [7] 滑秀云,邹红燕,张秀芳,等.Ⅰ期宫颈癌盆腔淋巴结转移危险因素分析.河南肿瘤医学,2002,10:256-257. [8] 张爱梅,单丹,李茹菊,等.手术治疗宫颈癌患者预后的相关因素分析.西南军医,2009,11:683-684.
2012, Vol. 21 
